Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl R Alving

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Vaccine|March 10, 2017
Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvantsLabdhi Seth, Karen M Bingham Ferlez, Stephen A Kaba, et al.
Vaccine|April 30, 2013
Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogsGary R Matyas, Alexander V Mayorov, Kenner C Rice, et al.
Analytical and Bioanalytical Chemistry|August 3, 2014
Characterization and optimization of heroin hapten-BSA conjugates: method development for the synthesis of reproducible hapten-based vaccinesOscar B Torres, Rashmi Jalah, Kenner C Rice, et al.
Journal of Virology|November 26, 2010
Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoireNicholas J Steers, Jeffrey R Currier, Gustavo H Kijak, et al.
Infection and Immunity|March 16, 2002
Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneouslyFernando Güereña-Burgueño, Eric R Hall, David N Taylor, et al.
Scientific Reports|June 3, 2015
TFH cells accumulate in mucosal tissues of humanized-DRAG mice and are highly permissive to HIV-1Atef Allam, Sai Majji, Kristina Peachman, et al.
Bioconjugate Chemistry|May 14, 2015
Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriersRashmi Jalah, Oscar B Torres, Alexander V Mayorov, et al.
Journal of Medicinal Chemistry|December 14, 2017
A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of AbuseAgnieszka Sulima, Rashmi Jalah, Joshua F G Antoline, et al.
Vaccine|February 4, 2014
Facial recognition of heroin vaccine opiates: type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphineGary R Matyas, Kenner C Rice, Kejun Cheng, et al.
Nature Medicine|March 4, 2003
F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulinsMilan Basta, Fredric Van Goor, Stefano Luccioli, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Vaccine|March 10, 2017
Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvantsLabdhi Seth, Karen M Bingham Ferlez, Stephen A Kaba, et al.
Vaccine|April 30, 2013
Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogsGary R Matyas, Alexander V Mayorov, Kenner C Rice, et al.
Analytical and Bioanalytical Chemistry|August 3, 2014
Characterization and optimization of heroin hapten-BSA conjugates: method development for the synthesis of reproducible hapten-based vaccinesOscar B Torres, Rashmi Jalah, Kenner C Rice, et al.
Journal of Virology|November 26, 2010
Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoireNicholas J Steers, Jeffrey R Currier, Gustavo H Kijak, et al.
Infection and Immunity|March 16, 2002
Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneouslyFernando Güereña-Burgueño, Eric R Hall, David N Taylor, et al.
Scientific Reports|June 3, 2015
TFH cells accumulate in mucosal tissues of humanized-DRAG mice and are highly permissive to HIV-1Atef Allam, Sai Majji, Kristina Peachman, et al.
Bioconjugate Chemistry|May 14, 2015
Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriersRashmi Jalah, Oscar B Torres, Alexander V Mayorov, et al.
Journal of Medicinal Chemistry|December 14, 2017
A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of AbuseAgnieszka Sulima, Rashmi Jalah, Joshua F G Antoline, et al.
Vaccine|February 4, 2014
Facial recognition of heroin vaccine opiates: type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphineGary R Matyas, Kenner C Rice, Kejun Cheng, et al.
Nature Medicine|March 4, 2003
F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulinsMilan Basta, Fredric Van Goor, Stefano Luccioli, et al.
Pageof 11